# Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

> **NIH NIH R44** · CURI BIO INC · 2020 · $750,000


## Key facts

- **NIH application ID:** 10012386
- **Project number:** 4R44HL149566-02
- **Recipient organization:** CURI BIO INC
- **Principal Investigator:** Nicholas Andrew Geisse
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $750,000
- **Award type:** 4N
- **Project period:** 2019-09-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10012386

## Citation

> US National Institutes of Health, RePORTER application 10012386, Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing (4R44HL149566-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10012386. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*